Skip to main content

Boundless Bio, Inc.

BOLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001782303

In the last 90 days, Boundless Bio, Inc. insiders filed 5 open-market purchases and 1 sale; 40 institutions reported holding it in 13F filings for Q2 2026, worth $38.3M in total; no superinvestor holds it.

SEC filings

10-K, 10-Q, 8-K, 20-F and 40-F reports Boundless Bio, Inc. filed with the SEC, newest first.

Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.

SEC filings by Boundless Bio, Inc.
FiledForm8-K itemsPeriodDocumentFiling index
Nov 10, 202610-Q–Sep 30, 2026SECIndex
Aug 28, 20268-K1.019.01Aug 28, 2026SECIndex
Aug 7, 202610-Q–Jun 30, 2026SECIndex
Jun 23, 20268-K1.012.053.025.015.027.018.019.01Jun 22, 2026SECIndex
Jun 17, 20268-K5.07Jun 15, 2026SECIndex
May 8, 202610-Q–Mar 31, 2026SECIndex
May 8, 20268-K2.029.01May 8, 2026SECIndex
Apr 13, 20268-K1.022.03Apr 13, 2026SECIndex
Mar 9, 202610-K–Dec 31, 2025SECIndex
Mar 9, 20268-K2.025.029.01Mar 3, 2026SECIndex
Nov 5, 202510-Q–Sep 30, 2025SECIndex
Nov 5, 20258-K2.029.01Nov 5, 2025SECIndex
Aug 5, 202510-Q–Jun 30, 2025SECIndex
Aug 5, 20258-K2.029.01Aug 5, 2025SECIndex
Jun 23, 20258-K5.07Jun 23, 2025SECIndex
May 23, 20258-K2.058.01May 23, 2025SECIndex
May 9, 202510-Q–Mar 31, 2025SECIndex
May 9, 20258-K2.029.01May 9, 2025SECIndex
Apr 1, 20258-K1.019.01Apr 1, 2025SECIndex
Mar 27, 202510-K–Dec 31, 2024SECIndex
Mar 27, 20258-K2.029.01Mar 27, 2025SECIndex
Dec 12, 20248-K5.027.018.019.01Dec 6, 2024SECIndex
Nov 7, 202410-Q–Sep 30, 2024SECIndex
Nov 7, 20248-K2.029.01Nov 7, 2024SECIndex
Oct 15, 20248-K5.02Oct 11, 2024SECIndex
Aug 20, 20248-K5.02Aug 19, 2024SECIndex
Aug 12, 20248-K2.029.01Aug 12, 2024SECIndex
Aug 12, 202410-Q–Jun 30, 2024SECIndex
May 13, 202410-Q–Mar 31, 2024SECIndex
May 13, 20248-K2.027.019.01May 13, 2024SECIndex
Apr 2, 20248-K5.038.019.01Apr 2, 2024SECIndex